Johannes J Duvekot Selected Research

Ketanserin

6/2015

Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johannes J Duvekot Research Topics

Disease

15	Pre-Eclampsia (Preeclampsia) 12/2020 - 10/2010
9	Premature Birth (Birth, Premature) 11/2016 - 06/2007
5	Postpartum Hemorrhage 01/2022 - 02/2009
5	Hypertension (High Blood Pressure) 01/2022 - 05/2010
5	Premature Obstetric Labor (Premature Labor) 02/2017 - 09/2009
4	Birth Weight (Birth Weights) 11/2016 - 09/2011
3	Hemorrhage 11/2019 - 05/2012
3	Fetal Growth Retardation (Intrauterine Growth Retardation) 11/2015 - 04/2012
3	Perinatal Death 02/2015 - 09/2011
2	Fetal Distress 01/2022 - 01/2016
2	Infections 01/2021 - 01/2019
2	Thrombophilia 10/2017 - 11/2015
2	Protein S Deficiency (Deficiency, Protein S) 10/2017 - 11/2015
2	Protein C Deficiency 10/2017 - 11/2015
2	Uterine Hemorrhage (Uterine Bleeding) 02/2017 - 09/2015
2	Infarction (Infarctions) 11/2015 - 05/2006
2	Lacerations 02/2015 - 02/2015
2	Breech Presentation 04/2010 - 04/2008
1	Tachycardia (Tachyarrhythmias) 06/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Placenta Accreta 01/2021
1	Type 1 von Willebrand Disease 11/2019
1	Uterine Rupture 01/2019
1	Cicatrix (Scar) 04/2018
1	Ectopic Pregnancy 04/2018
1	Thrombosis (Thrombus) 10/2017
1	Epilepsy (Aura) 02/2017
1	Seizures (Absence Seizure) 02/2017
1	Hyperlipidemias (Hyperlipidemia) 02/2017
1	Fetal Weight 11/2016
1	Nausea 01/2016
1	Dehydration (Water Stress) 01/2016
1	Hyperemesis Gravidarum 01/2016
1	Gestational Weight Gain 01/2016
1	Vomiting 01/2016
1	Malnutrition (Nutritional Deficiencies) 01/2016
1	Activated Protein C Resistance (APC Resistance) 11/2015
1	Urinary Tract Infections (Urinary Tract Infection) 02/2015

Drug/Important Bio-Agent (IBA)

7	Fibronectins (Fibronectin)IBA 02/2017 - 09/2009
5	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 04/2013
4	Biomarkers (Surrogate Marker)IBA 09/2021 - 11/2010
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 09/2009
3	Nicardipine (Dagan)FDA LinkGeneric 01/2022 - 05/2010
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2017
3	Nifedipine (Adalat)FDA LinkGeneric 05/2016 - 05/2014
2	FibrinIBA 09/2021 - 05/2006
2	Hemoglobins (Hemoglobin)IBA 01/2019 - 01/2007
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2019 - 05/2016
2	factor V LeidenIBA 10/2017 - 11/2015
2	Prothrombin (Factor II)IBA 10/2017 - 11/2015
2	atosibanIBA 05/2016 - 03/2009
2	Pharmaceutical PreparationsIBA 06/2015 - 03/2009
2	Progesterone FDA LinkGeneric 10/2011 - 06/2007
2	Tocolytic Agents (Tocolytics)IBA 09/2009 - 03/2009
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2022
1	Fibrinogen (Factor I)FDA Link 09/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Cerebrospinal Fluid ProteinsIBA 12/2020
1	Calcium-Binding ProteinsIBA 12/2020
1	von Willebrand FactorIBA 11/2019
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019
1	S100 Calcium Binding Protein A6IBA 01/2019
1	Levonorgestrel (Plan B)FDA LinkGeneric 04/2018
1	AntithrombinsIBA 10/2017
1	AnticoagulantsIBA 10/2017
1	Protein CIBA 10/2017
1	Carnitine (L-Carnitine)FDA LinkGeneric 02/2017
1	Lamotrigine (Lamictal)FDA LinkGeneric 02/2017
1	VitaminsIBA 02/2017
1	Soaps (Soap)IBA 02/2017
1	ProteomeIBA 01/2017
1	antineoplaston A10 (A 10)IBA 11/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	AntibodiesIBA 11/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2015
1	C-Reactive ProteinIBA 09/2015
1	DihydralazineIBA 06/2015
1	KetanserinIBA 06/2015
1	Analgesics (Analgesic Drugs)IBA 02/2015

Therapy/Procedure

10	Cesarean Section (Caesarean Section) 06/2022 - 01/2007
6	Therapeutics 01/2022 - 10/2008
4	Tocolysis 05/2016 - 03/2009
4	Induced Labor 02/2015 - 04/2012
3	Aftercare (After-Treatment) 01/2016 - 04/2008
2	Hysterectomy 01/2021 - 01/2019
2	Conservative Treatment 01/2019 - 05/2012
2	Length of Stay 01/2016 - 12/2010
2	Moxibustion 04/2010 - 04/2008
1	Artificial Respiration (Mechanical Ventilation) 06/2022
1	Thrombolytic Therapy 01/2022
1	Repeat Cesarean Section 01/2019
1	Stents 01/2019
1	Catheters 01/2019
1	Intrauterine Devices (Intrauterine Device) 04/2018
1	Contraception (Birth Control) 04/2018
1	Ketogenic Diet 02/2017
1	Enteral Nutrition (Feeding, Tube) 01/2016
1	Erythrocyte Transfusion 02/2015